In the current study, we have expanded our analyses into all molecular subtypes, including both transcriptomic and proteomic analyses of muscle biopsies from patients with HER2/neu-overexpressing tumors, and significantly increased our sample size to create, to our knowledge, the largest study of transcriptomic and proteomic changes in muscle of women with BC. The gene discussed is ERBB2; the disease is breast cancer.